Filing Details
- Accession Number:
- 0001133416-24-000070
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-26 08:18:48
- Reporting Period:
- 2024-12-23
- Accepted Time:
- 2024-12-26 08:18:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1725595 | Joel Lewis | C/O Galectin Therapeutics Inc. 4960 Peachtree Industrial Blvd., Ste 240 Norcross GA 30071 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-23 | 56,000 | $0.00 | 953,012 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-23 | 56,000 | $0.89 | 897,012 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2024-12-23 | 56,000 | $0.00 | 56,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,000 | Indirect | as UTMA custodian for a minor child |
Footnotes
- Shares of common stock acquired for no additional consideration resulting from vesting of Restricted Stock units.
- Shares of common stock sold pursuant to previously disclosed 10b5-1 plan.
- Restricted Stock Units disposed upon conversion into shares of common stock pursuant to vesting on December 20, 2024.
- These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is thebeneficial owner of these securities for purpose of Section 16 or for any other purpose.
- Multiple transactions ranging from $0.92 to $0.85 with an average of $0.8859.
Billionaire Hedge Funds
